Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
Experimental Hematology|March 9, 2004
Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysisIzhar Hardan, Rachel Rothman, Alain Gelibter, et al.
Bone Marrow Transplantation|February 19, 2020
LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantationRoni Shouval, Omer Teper, Joshua A Fein, et al.
The Oncologist|December 7, 2014
Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNoga Shem-Tov, Myriam Labopin, Leila Moukhtari, et al.
Journal of Clinical Apheresis|September 12, 2016
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomasGwendolyn van Gorkom, Herve Finel, Sebastian Giebel, et al.
Leukemia|June 29, 2018
The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantationJoshua A Fein, Avichai Shimoni, Myriam Labopin, et al.
Bone Marrow Transplantation|June 30, 2021
High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphomaMika Geva, Angharad Pryce, Roni Shouval, et al.
Journal of Clinical Immunology|October 22, 2013
Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cellsShomron Ben-Horin, Sylvie Polak-Charcon, Iris Barshack, et al.
European Journal of Haematology|November 7, 2020
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemiaJonathan Canaani, Ivetta Danylesko, Noga Shemtov, et al.
Journal of Hematology & Oncology|November 26, 2020
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein responseKatia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Antiviral Research|March 30, 2011
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationDana G Wolf, Avichai Shimoni, Igor B Resnick, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Experimental Hematology|March 9, 2004
Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysisIzhar Hardan, Rachel Rothman, Alain Gelibter, et al.
Bone Marrow Transplantation|February 19, 2020
LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantationRoni Shouval, Omer Teper, Joshua A Fein, et al.
The Oncologist|December 7, 2014
Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNoga Shem-Tov, Myriam Labopin, Leila Moukhtari, et al.
Journal of Clinical Apheresis|September 12, 2016
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomasGwendolyn van Gorkom, Herve Finel, Sebastian Giebel, et al.
Leukemia|June 29, 2018
The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantationJoshua A Fein, Avichai Shimoni, Myriam Labopin, et al.
Bone Marrow Transplantation|June 30, 2021
High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphomaMika Geva, Angharad Pryce, Roni Shouval, et al.
Journal of Clinical Immunology|October 22, 2013
Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cellsShomron Ben-Horin, Sylvie Polak-Charcon, Iris Barshack, et al.
European Journal of Haematology|November 7, 2020
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemiaJonathan Canaani, Ivetta Danylesko, Noga Shemtov, et al.
Journal of Hematology & Oncology|November 26, 2020
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein responseKatia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Antiviral Research|March 30, 2011
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationDana G Wolf, Avichai Shimoni, Igor B Resnick, et al.
Pageof 17